Fostamatinib in the Treatment of Chronic Active Antibody Mediated Rejection
Fostamatinib in the Treatment of Chronic Active Antibody Mediated Rejection
Active, not recruiting · NCT03991780 · Registry updated 2024-11-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Fostamatinib in the Treatment of Chronic Active Antibody Mediated Rejection | Renal Transplant Rejection | Active, not recruiting | Phase 1 / Phase 2 | 2024-11-25 | NCT03991780 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Imperial College London | 220 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Imperial College NHS Healthcare Trust | London | United Kingdom | 1 |